OtherShort Communication
The contributions of cytochrome P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors (PDE5Is) sildenafil, udenafil, and vardenafil
Hei-Young Ku, Hee-Jeong Ahn, Kyung-Ah Seo, Hyunmi Kim, Minkyung Oh, Soo Kyung Bae, Jae-Gook Shin, Ji-Hong Shon and Kwang-Hyeon Liu
Drug Metabolism and Disposition February 28, 2008, DOI: https://doi.org/10.1124/dmd.107.020099
Hei-Young Ku
Hee-Jeong Ahn
Kyung-Ah Seo
Hyunmi Kim
Minkyung Oh
Soo Kyung Bae
Jae-Gook Shin
Ji-Hong Shon
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherShort Communication
The contributions of cytochrome P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors (PDE5Is) sildenafil, udenafil, and vardenafil
Hei-Young Ku, Hee-Jeong Ahn, Kyung-Ah Seo, Hyunmi Kim, Minkyung Oh, Soo Kyung Bae, Jae-Gook Shin, Ji-Hong Shon and Kwang-Hyeon Liu
Drug Metabolism and Disposition February 28, 2008, DOI: https://doi.org/10.1124/dmd.107.020099
OtherShort Communication
The contributions of cytochrome P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors (PDE5Is) sildenafil, udenafil, and vardenafil
Hei-Young Ku, Hee-Jeong Ahn, Kyung-Ah Seo, Hyunmi Kim, Minkyung Oh, Soo Kyung Bae, Jae-Gook Shin, Ji-Hong Shon and Kwang-Hyeon Liu
Drug Metabolism and Disposition February 28, 2008, DOI: https://doi.org/10.1124/dmd.107.020099
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement